Volume 11, Number 6—June 2005
Research
Fluoroquinolone-resistant Escherichia coli Carriage in Long-Term Care Facility
Joel N. Maslow*†
, Betsy Lee*, and Ebbing Lautenbach†
, Betsy Lee*, and Ebbing Lautenbach†
Table 1
Comparison of cases and controls, fluoroquinolone-resistant Escherichia coli colonization study, long-term care facility*
| Variable | Controls (n = 24) (%) | Cases (n = 25) (%) | OR (95% CI) | p value† |
|---|---|---|---|---|
| Prior hospitalization | 18/24 (75.0) | 13/25 (52.0) | 0.36 (0.09, 1.41) | 0.08 |
| Duration of residence in facility (d)‡§ | 209.5 (22–2,571) | 411 (81–2,580) | 0.13 | |
| Decubitus ulcer | 6/24 (25.0) | 2/25 (8.0) | 0.26 (0.02, 1.73) | 0.14 |
| Low ambulatory status | 15/24 (62.5) | 10/25 (40.0) | 0.40 (0.11, 1.46) | 0.16 |
| Fluoroquinolone use | 6/24 (25.0) | 18/25 (72.0) | 7.71 (1.86, 33.60) | 0.002 |
| Metronidazole use | 1/24 (4.2) | 7/25 (28.0) | 8.90 (0.96, 420.17) | 0.05 |
*OR, odds ratio; 95% CI, 95% confidence interval.
†Fisher exact test (categorical variables); Wilcoxon-rank sum test (continuous variables).
‡Median (range).
§Days from admission into facility until study enrollment.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.